Sign in
Active, not recruitingNo phase

The GUARDIAN Pilot Trial

Key facts

Who runs it
The Cleveland Clinic
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
80 people, planned
Started
27 Apr 2021
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Tight pressure management
  • Routine pressure management
Record updated
17 March 2026

Who can take part

Age
45 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (32)Hide the full registry criteria

Who can take part

  • ≥45 years old
  • Scheduled for major noncardiac surgery expected to last at least 2 hours
  • Having general endotracheal, neuraxial anesthesia, or the combination
  • Expected to require at least overnight hospitalization
  • Are designated ASA physical status 2-4 (ranging from mild systemic disease through severe systemic disease that is a constant threat to life)
  • Chronically taking at least one anti-hypertensive medication
  • Expected to have direct blood pressure monitoring with an arterial catheter
  • Cared for by clinicians willing to follow the GUARDIAN protocol
  • Subject to at least one of the following risk factors:
  • History of peripheral arterial surgery
  • History of coronary artery disease
  • History of stroke or transient ischemic attack
  • Serum creatinine >175 µmol/L (>2.0 mg/dl)
  • Diabetes requiring medication
  • Current smoking or 15 pack-year history of smoking tobacco
  • Scheduled for major vascular surgery
  • Body mass index ≥35 kg/m2
  • Preoperative high-sensitivity troponin T >14 ng/L or troponin I equivalent
  • B-type natriuretic protein (BNP) >80 ng/L or N-terminal B-type natriuretic protein (NT-ProBNP) >100 ng/L

Who cannot take part

  • Are scheduled for carotid artery surgery
  • Are scheduled for intracranial surgery
  • Are scheduled for pheochromocytoma surgery
  • Are scheduled for liver transplantation
  • Require preoperative intravenous vasoactive medications
  • Have previously participated in this trial
  • Have a condition that precludes routine or tight blood pressure management such as surgeon request for relative hypotension
  • Have a documented history of dementia
  • Have end-stage renal disease requiring dialysis or estimated glomerular filtration rate (eGFR) <30 ml/min
  • Are scheduled for partial or complete nephrectomy
  • Require beach-chair positioning
  • Have language, vision, or hearing impairments that may compromise cognitive assessments
  • Have contraindications to norepinephrine or phenylephrine per clinician judgement

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The treatments will be: 1) norepinephrine or phenylephrine infusion to maintain intraoperative MAP ≥85 mmHg, delayed resumption of chronic antihypertensive medications, and a target ward MAP ≥80 mmHg (tight pressure management); or, 2) routine intraoperative blood pressure management and prompt resumption of chronic antihypertensive medications (routine pressure management).

The 2 groups in the trial

  • Tight pressure managementTreatment being tested

    Patients assigned to tight blood pressure control angiotensin converting enzyme inhibitors and angiotensin receptor blockers will not be given the morning of surgery. Other chronic antihypertensives will only be given as necessary to treat hypertension. Norepinephrine or phenylephrine infusion will be infused at a rate sufficient to maintain intraoperative MAP ≥ 85 mmHg. Resumption of chronic anti-hypertensive medications will be delayed until the third postoperative day unless deemed necessary to treat hypertension or for some other clear indication. The target for postoperative systolic arterial pressures ≥110 mmHg during the initial three postoperative days.

  • Routine pressure managementOther group

    ACEIs, ARBs, and/or calcium channel blockers can be given the morning of surgery if deemed appropriate by the attending anesthesiologist. Intraoperative blood pressure will be managed per clinical routine. As usual, chronic anti-hypertensive medications will be restarted shortly after surgery unless contraindicated by hypotension.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Pilot Trial
Publications
Record updated
17 March 2026